{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:59:06Z","timestamp":1785859146615,"version":"3.56.0"},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p>\n                    A 72-year-old man with castration-resistant prostate adenocarcinoma underwent\n                    <jats:sup>68<\/jats:sup>\n                    Ga-PSMA-11 PET\/CT for restaging due to significantly increased PSA levels during chemotherapy. Imaging revealed high\n                    <jats:sup>68<\/jats:sup>\n                    Ga-PSMA-11 uptake in bilateral adrenal uptake, with additional uptake in the prostate and few sclerotic bone lesions. MRI and afterwards adrenal gland biopsy confirmed adrenal metastases, an uncommon metastatic site. As the patient was oligometastatic, refractory to previous systemic therapies, and ineligible for surgery or radiotherapy,\n                    <jats:sup>177<\/jats:sup>\n                    Lu-PSMA-617 radioligand therapy was initiated. After four treatment cycles, PSA levels progressively decreased, and post-therapeutic follow-up SPECT\/CT demonstrated a near-complete response in adrenal and bone metastases without treatment-related adverse effects.\n                  <\/jats:p>","DOI":"10.1097\/rlu.0000000000006648","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:06:36Z","timestamp":1785855996000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Near-complete Response of Bilateral Adrenal Metastases to 177Lu-PSMA Therapy in Castration-resistant Prostate Cancer on Posttherapeutic SPECT-CT Follow Up"],"prefix":"10.1097","author":[{"given":"Burcak","family":"Yilmaz","sequence":"first","affiliation":[{"name":"Nuclear Medicine Department, Biruni University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulhan","family":"Ozkanli","sequence":"additional","affiliation":[{"name":"Medical Oncology Department, Health Sciences University, Haydarpasa Numune Education and Research Hospital, Istanbul"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emre","family":"\u00d6zcan","sequence":"additional","affiliation":[{"name":"Pathology Department, Kocaeli City Hospital, Kocaeli"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunus Emre","family":"Akp\u0131nar","sequence":"additional","affiliation":[{"name":"Radiology Department, Biruni University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esra","family":"Civriz","sequence":"additional","affiliation":[{"name":"Pathology Department, Kocaeli City Hospital, Kocaeli"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeynep","family":"Hudayioglu","sequence":"additional","affiliation":[{"name":"Istanbul University-Cerrahpasa, Medical Faculty, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilkmen Nesrin","family":"Aslan","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Department, Biruni University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,7,31]]},"reference":[{"key":"R1-20260804","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1055\/s-0044-1786012","article-title":"The role of 68 Ga PSMA imaging in evaluating adrenal lesions in prostate cancer patients","volume":"23","author":"\u00dcst\u00fcn","year":"2024","journal-title":"World J Nucl Med"},{"key":"R2-20260804","first-page":"e75985","article-title":"Isolated bilateral adrenal metastasis in castration-resistant prostate cancer: a case report and literature review","volume":"16","author":"Barali","year":"2024","journal-title":"Cureus"},{"key":"R3-20260804","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1053\/hp.2000.6698","article-title":"Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients","volume":"31","author":"Bubendorf","year":"2000","journal-title":"Hum Pathol"},{"key":"R4-20260804","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1097\/RLU.0000000000003759","article-title":"68Ga-PSMA-11 PET\/CT in isolated bilateral adrenal metastases from prostate adenocarcinoma","volume":"47","author":"Zhao","year":"2022","journal-title":"Clin Nucl Med"},{"key":"R5-20260804","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/RLU.0000000000002064","article-title":"Prostate-specific membrane antigen expression in adrenocortical carcinoma on 68Ga-prostate-specific membrane antigen PET\/CT","volume":"43","author":"Arora","year":"2018","journal-title":"Clin Nucl Med"},{"key":"R6-20260804","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1007\/s00259-023-06255-8","article-title":"Joint EANM\/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMARLT)","volume":"50","author":"Kratochwil","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R7-20260804","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1097\/RLU.0000000000004964","article-title":"Isolated adrenal metastases of castration-resistant prostate cancer: excellent response to 177 Lu-PSMA with no adrenal insufficiency","volume":"49","author":"Topal","year":"2024","journal-title":"Clin Nucl Med"},{"key":"R8-20260804","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1159\/000545983","article-title":"MRI-guided adaptive radiation therapy for oligometastatic prostate cancer involving the adrenal gland: a case report and literature review","volume":"18","author":"Bolte","year":"2025","journal-title":"Case Rep Oncol"},{"key":"R9-20260804","doi-asserted-by":"crossref","first-page":"557","DOI":"10.2340\/1651-226X.2024.40017","article-title":"177Lu-PSMA radioligand therapy for isolated bilateral adrenal metastases from prostate cancer","volume":"63","author":"Perrone","year":"2024","journal-title":"Acta Oncol"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/RLU.0000000000006648","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:06:38Z","timestamp":1785855998000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/RLU.0000000000006648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,31]]},"references-count":9,"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000006648","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,31]]},"assertion":[{"value":"2026-05-01","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-08","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}